Bioanalytical Systems Inc. Daily Stock Analysis

Daily Stock Analysis, BASI, Bioanalytical Systems Inc, priceseries

Bioanalytical Systems Inc. Daily Stock Analysis
Stock Information
Open
26.01
Close
26.39
High
27.81
Low
25.35
Previous Close
26.06
Daily Price Gain
0.33
YTD High
30.43
YTD High Date
May 10, 2021
YTD Low
0.60
YTD Low Date
Nov 11, 2016
YTD Price Change
25.34
YTD Gain
2413.33%
52 Week High
30.43
52 Week High Date
May 10, 2021
52 Week Low
12.81
52 Week Low Date
Mar 16, 2021
52 Week Price Change
7.62
52 Week Gain
40.60%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 10. 2017
0.90
Feb 21. 2017
1.02
6 Trading Days
13.79%
Link
LONG
Feb 24. 2017
1.26
Mar 15. 2017
1.55
13 Trading Days
23.25%
Link
LONG
May 1. 2017
1.25
May 22. 2017
1.57
15 Trading Days
25.85%
Link
LONG
Nov 13. 2017
2.01
Dec 19. 2017
2.68
25 Trading Days
33.57%
Link
LONG
Jun 29. 2018
1.65
Jul 16. 2018
1.80
10 Trading Days
9.29%
Link
LONG
Feb 27. 2019
1.50
Apr 5. 2019
2.03
27 Trading Days
35.26%
Link
LONG
Aug 16. 2019
2.08
Sep 26. 2019
3.73
28 Trading Days
79.35%
Link
LONG
Oct 10. 2019
3.68
Nov 19. 2019
5.01
28 Trading Days
36.03%
Link
LONG
Dec 30. 2019
4.89
Jan 3. 2020
5.32
3 Trading Days
8.90%
Link
LONG
Jan 6. 2020
4.97
Jan 23. 2020
5.35
12 Trading Days
7.70%
Link
LONG
May 21. 2020
4.65
Jun 8. 2020
5.01
11 Trading Days
7.72%
Link
LONG
Nov 11. 2020
5.49
Jan 25. 2021
14.07
49 Trading Days
156.35%
Link
LONG
Mar 29. 2021
18.85
Apr 20. 2021
20.37
15 Trading Days
8.07%
Link
LONG
Apr 23. 2021
21.12
May 12. 2021
25.28
13 Trading Days
19.70%
Link
Company Information
Stock Symbol
BASI
Exchange
NasdaqCM
Company URL
http://www.basinc.com
Company Phone
3174634527
CEO
Philip A. Downing
Headquarters
Indiana
Business Address
2701 KENT AVE, WEST LAFAYETT, IN 47906-1382
Sector
Equity
Industry Category
Diversified Services
Industry Group
Research Services
CIK
0000720154
About

Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through two business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Description

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, other North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading